From microbiology to antimicrobial stewardship
How microbiological diagnosis, result interpretation, resistance surveillance, antimicrobial use and evaluation of clinical and economic outcomes fit together.
AMR surveillance
7Materials on local and regional antimicrobial resistance surveillance methods, source-data quality, and the use of results in clinical and management practice.
AMR in Russia: Key Findings from the 2025 Report
Key results of the 2025 analytical report by the Methodological Verification Center on antimicrobial resistance: pathogen structure among hospitalized patients, resistance levels, carbapenemases, and practical conclusions regarding antimicrobial agents.
YNAO: A Regional AMR Surveillance System
A review of the 2025 CMAC publication: the experience of the Yamalo-Nenets Autonomous Okrug in implementing a regional system for automated validation of microbiology reports, continuous AMR surveillance, and real-time analytics.
Botkin Hospital: From Data Exports to Continuous Surveillance
Review of a Poliklinika journal article (2024): how the Botkin Hospital centralized bacteriology lab built an IT-enabled production flow (LIS + services), why export-based surveillance does not scale, and how the next-generation system – ABioGram – adds automated report validation and real-time AMR surveillance.
Moscow’s Largest Laboratory: Faster Result Validation
Pilot results in the largest laboratory in Moscow (07 Nov–25 Nov 2025): API integration with the laboratory information system, automated interpretation of antimicrobial susceptibility results, 89,117 decision-support messages, and real-time AMR analytics.
NMRC LRC: A Closed Digital AMR Surveillance Loop
Review of a CMAC (2025) publication: implementation of an integrated digital loop (LIS–ABioGram–HIS), automated antibiogram validation, continuous AMR surveillance, and the impact of expert comments on clinical decision-making.
Local AMR Surveillance: Comparing Guidelines
A review from CMAC (2025) compares WHO GLASS, CLSI M39, ESCMID, AMRcloud guidance and Russian MR 3.1.0346-24–highlighting key contradictions that matter for local antibiograms, data quality, and stewardship decisions.